Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Andrea B. Apolo
Based on 28 articles published since 2009
(Why 28 articles?)
||||
Expertise Level
The expertise of Andrea B. Apolo ranks in the Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Apolo, Andrea   ·   Apolo, Andrea B
Work Locations
Details
Most likely:    National Institutes of Health      
2019
  • Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany. · Center for Cancer Research, National Cancer Institute, NIH Maryland, Bethesda, USA. · Guy's and St, Thomas' Hospital, Great Maze Pond, London, UK. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA. · Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Yale Cancer Center, New Haven, CT, USA. · Barts Cancer Institute, London, USA. · Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medical Oncology, Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Pubmed 30238401
2018
  • Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive Room 12N226, Bethesda, MD, 20892, USA. · Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive Room 12N226, Bethesda, MD, 20892, USA. · Pubmed 29808294
  • Barts Cancer Institute, Queen Mary University of London, St Bartholomew's Hospital, London, UK. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · EMD Serono Inc, Billerica, MA, USA. · Global Medical Affairs, ImmunoOncology, Pfizer Oncology, New York, NY, USA. · Bladder Cancer Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address: · Pubmed 29325739
  • The University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address: · Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland. · Moffit Cancer Center, Tampa, Florida. · University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 29113841
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Penn State Milton S. Hershey Medical Center, Hershey, PA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA. · National Cancer Institute, National Institutes of Health, Bethesda, MD. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · The University of Chicago, Chicago, IL. · Fred Hutchinson Cancer Research Center, Seattle, WA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Stanford University School of Medicine, Stanford, CA. · University of Wisconsin, Madison, WI. · Cancer Research UK/Medical Research Council, Oxford Institute for Radiation Oncology, Oxford, United Kingdom. · Roswell Park Cancer Institute, Buffalo, NY. · Johns Hopkins University School of Medicine, Baltimore, MD. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29289519
2016
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Medical College of Cornell University, New York, New York. · Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26618338
2015
  • aGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA bDepartment of Urology Caritas St. Josef Medical Centre University of Regensburg, Germany. · Pubmed 26153639
  • From the Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD; US Oncology Research, Houston, TX and Comprehensive Cancer Centers of Nevada, Las Vegas, NV; University of Colorado Cancer Center, Denver, CO. · Pubmed 25993148
  • Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 CRC, B2-3500, Bethesda, MD 20892, USA. · Bladder Cancer Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive 12N226, MSC 1906, Bethesda, MD 20892, USA. · Bladder Cancer Section, Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2W-5940, Bethesda, MD 20892-1210, USA. · Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 CRC, B2-3500, Bethesda, MD 20892, USA. Electronic address: · Pubmed 25882559
  • Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD. · Bladder Cancer Advocacy Network, Bethesda, MD. · Department of Urology, Penn State Hershey Medical Center, Hershey, PA. · Department of Urology, Baylor College of Medicine, Houston, TX. · Department of Urology, University of Michigan Health System, Ann Arbor, MI. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · University of Colorado Cancer Center, Denver, CO. · Department of Pathology, MD Anderson Cancer Center, Houston, TX. · Harvard Medical School, Massachusetts General Hospital, Boston, MA. · Department of Immunology, Institut Pasteur, Paris, France. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. · Department of Urology, MD Anderson Cancer Center, Houston, TX. · Department of Medical Oncology, Mount Sinai Hospital, New York, NY. · Department of Pathology, University of California, La Jolla, San Diego, CA. · Department of Urology, University of North Carolina, Chapel Hill, NC. · Department of Urology, University of Rochester Medical Center, Rochester, NY. · Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: · Pubmed 25065704
  • Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Prostate and Urologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland4section editor, JAMA Dermatology. · Pubmed 25427282
2014
  • Hospital San Camillo-Forlanini, Rome, Italy · Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. · Pubmed 24821880
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Clinical Research Directorate/Clinical Monitoring Research Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom. · Laboratory of Pathology, Center of Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Maine Cancer Registry, Augusta, Maine. · Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. · Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. · Vermont Cancer Registry, Burlington, Vermont. · Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Department of Pathology and Laboratory Medicine, Maine Medical Center, Portland, Maine. · Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont. · New Hampshire State Cancer Registry, Concord, New Hampshire. · Spanish National Cancer Research Centre, Madrid, Spain. · Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. National School of Public Health, Athens, Greece. CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain. · CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain. Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain. · CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain. Universitat Pompeu Fabra, Barcelona, Spain. · Ramón y Cajal Hospital, Madrid, Spain. · Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain. · Hospital del Mar-IMIM, Univesitat Pompeu Fabra, Barcelona, Spain. · Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri. · School of Public Health, Imperial College London, London, United Kingdom. Human Genetics Foundation (HuGeF), Torino, Italy. · School of Public Health, Imperial College London, London, United Kingdom. · National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom. Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. Hellenic Health Foundation, Athens, Greece. · Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden. · Human Genetics Foundation (HuGeF), Torino, Italy. Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, University of Melbourne, Australia. · Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway. Department of Research, Cancer Registry of Norway, Oslo, Norway. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Samfundet Folkhälsan, Helsinki, Finland. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Public Health Division of Gipuzkoa, Basque Regional Health Department and Ciberesp-Biodonostia, San Sebastian, Spain. · Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom. · Danish Cancer Society Research Center, Copenhagen, Denmark. · International Agency for Research on Cancer, Lyon, France. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia. · National Institute for Health and Welfare, Helsinki, Finland. · Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington. · Department of Obstetrics and Gynecology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. Department of Preventive Medicine, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Department of Preventive Medicine, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saude (SERGAS), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York. · University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · AP-HP, Hopital Tenon, GHU-Est, Department of Urology, Paris, France. Centre de Recherche sur les Pathologies Prostatiques, Paris, France. UPMC Univ Paris 06, ONCOTYPE-URO, Paris, France. · Centre de Recherche sur les Pathologies Prostatiques, Paris, France. UPMC Univ Paris 06, ONCOTYPE-URO, Paris, France. · Centre de Recherche sur les Pathologies Prostatiques, Paris, France. UPMC Univ Paris 06, ONCOTYPE-URO, Paris, France. AP-HP, Hopital Pitie-Salpetriere, GHU-Est, Departments of Urology and Pathology, Paris, France. · Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy. · Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padua, Italy. · Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Cancer Genomics Research Laboratory, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland. · Information Management Services, Rockville, Maryland. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Pubmed 25320178
  • Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: · Pubmed 25108634
  • Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, MD. Electronic address: · Department of Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, CT. · Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY. · Biostatistics and Data Management Section, National Cancer Institute, NIH, Bethesda, MD. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Medical Oncology, Thomas Jefferson University, Kimmel Cancer Center, Philadelphia, PA. · Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD. · Department of Urology, Oregon Health and Science University, Portland, OR. · Division of Urology, Penn State Hershey Medical Center, Hershey, PA. · Developmental Therapeutics and Genitourinary Cancer Programs, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA. · US Oncology Research, Houston, TX; Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada. · Pubmed 24840869
  • Hospital San Camillo-Forlanini, Rome, Italy · National Cancer Institute, Bethesda, MD. · Pubmed 25385726
2012
  • Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20014, USA. · Pubmed 23218068
2015
  • aGenitourinary Malignancies Branch bDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA cDepartment of Urology, Medical University of Vienna, Vienna, Austria dCancer Research Unit, Warwick University Medical School, Coventry, UK. · Pubmed 26372038
  • aRadiology and Imaging Sciences, Clinical Center, National Institutes of Health bGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 26222929
  • aProstate and Urologic Cancers Program, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut bDevelopmental Therapeutics Branch cGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 25811346
2014
  • aGenitourinary Malignancies Branch bUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 24685646
  • 1 National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes, Endocrine, and Obesity Branch, National Institutes of Health , Bethesda, Maryland. · Pubmed 24724719
  • Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bldg 10, Hatfield Clinical Research Center, Rm 2 W-3952 10 Center Drive MSC 1210, 20892-1210, Bethesda, MD, USA. · Pubmed 25335552
2013
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 8717 Grovemont Cir, Bethesda, MD 20892-4605, USA. · Pubmed 23266392
Probable:    University of Colorado system      
2015
  • From the Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD; US Oncology Research, Houston, TX and Comprehensive Cancer Centers of Nevada, Las Vegas, NV; University of Colorado Cancer Center, Denver, CO. · Pubmed 25993148
Probable:    University of Regensburg      
2015
  • aGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA bDepartment of Urology Caritas St. Josef Medical Centre University of Regensburg, Germany. · Pubmed 26153639
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 28 total) written by Andrea B. Apolo about Urinary Bladder Neoplasms:

  • SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer. 2019
  • Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma. 2018
  • Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development. 2018
  • Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma. 2018
  • Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer. 2018
  • The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. 2016
  • A precision, personalized approach to the management of bladder cancer. 2015
  • Immunotherapies for bladder cancer: a new hope. 2015
  • Imaging muscle-invasive and metastatic urothelial carcinoma. 2015
  • New and promising strategies in the management of bladder cancer. 2015
Show List of Full Article Records
Google Searches

Learn more about Andrea B. Apolo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Institutes of Health
University of Colorado system
University of Regensburg
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Institutes of Health
2019
  • Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany. · Center for Cancer Research, National Cancer Institute, NIH Maryland, Bethesda, USA. · Guy's and St, Thomas' Hospital, Great Maze Pond, London, UK. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA. · Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Yale Cancer Center, New Haven, CT, USA. · Barts Cancer Institute, London, USA. · Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medical Oncology, Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Pubmed 30238401
2018
  • Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive Room 12N226, Bethesda, MD, 20892, USA. · Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive Room 12N226, Bethesda, MD, 20892, USA. · Pubmed 29808294
  • Barts Cancer Institute, Queen Mary University of London, St Bartholomew's Hospital, London, UK. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · EMD Serono Inc, Billerica, MA, USA. · Global Medical Affairs, ImmunoOncology, Pfizer Oncology, New York, NY, USA. · Bladder Cancer Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address: · Pubmed 29325739
  • The University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address: · Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland. · Moffit Cancer Center, Tampa, Florida. · University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 29113841
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Penn State Milton S. Hershey Medical Center, Hershey, PA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA. · National Cancer Institute, National Institutes of Health, Bethesda, MD. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · The University of Chicago, Chicago, IL. · Fred Hutchinson Cancer Research Center, Seattle, WA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Stanford University School of Medicine, Stanford, CA. · University of Wisconsin, Madison, WI. · Cancer Research UK/Medical Research Council, Oxford Institute for Radiation Oncology, Oxford, United Kingdom. · Roswell Park Cancer Institute, Buffalo, NY. · Johns Hopkins University School of Medicine, Baltimore, MD. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29289519
2016
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Medical College of Cornell University, New York, New York. · Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26618338
2015
  • aGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA bDepartment of Urology Caritas St. Josef Medical Centre University of Regensburg, Germany. · Pubmed 26153639
  • From the Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD; US Oncology Research, Houston, TX and Comprehensive Cancer Centers of Nevada, Las Vegas, NV; University of Colorado Cancer Center, Denver, CO. · Pubmed 25993148
  • Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 CRC, B2-3500, Bethesda, MD 20892, USA. · Bladder Cancer Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive 12N226, MSC 1906, Bethesda, MD 20892, USA. · Bladder Cancer Section, Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2W-5940, Bethesda, MD 20892-1210, USA. · Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 CRC, B2-3500, Bethesda, MD 20892, USA. Electronic address: · Pubmed 25882559
  • Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD. · Bladder Cancer Advocacy Network, Bethesda, MD. · Department of Urology, Penn State Hershey Medical Center, Hershey, PA. · Department of Urology, Baylor College of Medicine, Houston, TX. · Department of Urology, University of Michigan Health System, Ann Arbor, MI. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · University of Colorado Cancer Center, Denver, CO. · Department of Pathology, MD Anderson Cancer Center, Houston, TX. · Harvard Medical School, Massachusetts General Hospital, Boston, MA. · Department of Immunology, Institut Pasteur, Paris, France. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. · Department of Urology, MD Anderson Cancer Center, Houston, TX. · Department of Medical Oncology, Mount Sinai Hospital, New York, NY. · Department of Pathology, University of California, La Jolla, San Diego, CA. · Department of Urology, University of North Carolina, Chapel Hill, NC. · Department of Urology, University of Rochester Medical Center, Rochester, NY. · Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: · Pubmed 25065704
  • Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Prostate and Urologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland4section editor, JAMA Dermatology. · Pubmed 25427282
2014
  • Hospital San Camillo-Forlanini, Rome, Italy · Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. · Pubmed 24821880
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Clinical Research Directorate/Clinical Monitoring Research Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom. · Laboratory of Pathology, Center of Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Maine Cancer Registry, Augusta, Maine. · Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. · Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. · Vermont Cancer Registry, Burlington, Vermont. · Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Department of Pathology and Laboratory Medicine, Maine Medical Center, Portland, Maine. · Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont. · New Hampshire State Cancer Registry, Concord, New Hampshire. · Spanish National Cancer Research Centre, Madrid, Spain. · Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. National School of Public Health, Athens, Greece. CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain. · CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain. Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain. · CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain. Universitat Pompeu Fabra, Barcelona, Spain. · Ramón y Cajal Hospital, Madrid, Spain. · Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain. · Hospital del Mar-IMIM, Univesitat Pompeu Fabra, Barcelona, Spain. · Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri. · School of Public Health, Imperial College London, London, United Kingdom. Human Genetics Foundation (HuGeF), Torino, Italy. · School of Public Health, Imperial College London, London, United Kingdom. · National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom. Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. Hellenic Health Foundation, Athens, Greece. · Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden. · Human Genetics Foundation (HuGeF), Torino, Italy. Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, University of Melbourne, Australia. · Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway. Department of Research, Cancer Registry of Norway, Oslo, Norway. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Samfundet Folkhälsan, Helsinki, Finland. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Public Health Division of Gipuzkoa, Basque Regional Health Department and Ciberesp-Biodonostia, San Sebastian, Spain. · Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom. · Danish Cancer Society Research Center, Copenhagen, Denmark. · International Agency for Research on Cancer, Lyon, France. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia. · National Institute for Health and Welfare, Helsinki, Finland. · Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington. · Department of Obstetrics and Gynecology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. Department of Preventive Medicine, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Department of Preventive Medicine, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saude (SERGAS), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York. · University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · AP-HP, Hopital Tenon, GHU-Est, Department of Urology, Paris, France. Centre de Recherche sur les Pathologies Prostatiques, Paris, France. UPMC Univ Paris 06, ONCOTYPE-URO, Paris, France. · Centre de Recherche sur les Pathologies Prostatiques, Paris, France. UPMC Univ Paris 06, ONCOTYPE-URO, Paris, France. · Centre de Recherche sur les Pathologies Prostatiques, Paris, France. UPMC Univ Paris 06, ONCOTYPE-URO, Paris, France. AP-HP, Hopital Pitie-Salpetriere, GHU-Est, Departments of Urology and Pathology, Paris, France. · Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy. · Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padua, Italy. · Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Cancer Genomics Research Laboratory, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland. · Information Management Services, Rockville, Maryland. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Pubmed 25320178
  • Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. · Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: · Pubmed 25108634
  • Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, MD. Electronic address: · Department of Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, CT. · Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY. · Biostatistics and Data Management Section, National Cancer Institute, NIH, Bethesda, MD. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Medical Oncology, Thomas Jefferson University, Kimmel Cancer Center, Philadelphia, PA. · Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD. · Department of Urology, Oregon Health and Science University, Portland, OR. · Division of Urology, Penn State Hershey Medical Center, Hershey, PA. · Developmental Therapeutics and Genitourinary Cancer Programs, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA. · US Oncology Research, Houston, TX; Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada. · Pubmed 24840869
  • Hospital San Camillo-Forlanini, Rome, Italy · National Cancer Institute, Bethesda, MD. · Pubmed 25385726
2012
  • Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20014, USA. · Pubmed 23218068
2015
  • aGenitourinary Malignancies Branch bDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA cDepartment of Urology, Medical University of Vienna, Vienna, Austria dCancer Research Unit, Warwick University Medical School, Coventry, UK. · Pubmed 26372038
  • aRadiology and Imaging Sciences, Clinical Center, National Institutes of Health bGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 26222929
  • aProstate and Urologic Cancers Program, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut bDevelopmental Therapeutics Branch cGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 25811346
2014
  • aGenitourinary Malignancies Branch bUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 24685646
  • 1 National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes, Endocrine, and Obesity Branch, National Institutes of Health , Bethesda, Maryland. · Pubmed 24724719
  • Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bldg 10, Hatfield Clinical Research Center, Rm 2 W-3952 10 Center Drive MSC 1210, 20892-1210, Bethesda, MD, USA. · Pubmed 25335552
2013
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 8717 Grovemont Cir, Bethesda, MD 20892-4605, USA. · Pubmed 23266392
University of Colorado system
2015
  • From the Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD; US Oncology Research, Houston, TX and Comprehensive Cancer Centers of Nevada, Las Vegas, NV; University of Colorado Cancer Center, Denver, CO. · Pubmed 25993148
University of Regensburg
2015
  • aGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA bDepartment of Urology Caritas St. Josef Medical Centre University of Regensburg, Germany. · Pubmed 26153639
Memorial Sloan-Kettering Cancer Center
2010
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 20679618
2009
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 19792967
5 Other Locations Show
Yearly article counts 14018921011
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.